• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

Paxlovid COVID-19 pill
HealthThe FDA is allowing pharmacists to prescribe COVID-19 pill Paxlovid
By Matthew Perrone, Tom Murphy and The Associated PressJuly 6, 2022
FDA bans Juul e-cigarettes
HealthFDA bans Juul e-cigarettes amid spike in teen vaping
By Matthew Perrone and The Associated PressJune 23, 2022
A nurse prepares a pediatric dose of the Pfizer-BioNTech Covid-19 vaccine.
HealthFDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
By Matthew Perrone, Lauran Neergaard and The Associated PressMay 5, 2022
Man receives Pfizer COVID vaccine
HealthFDA approves additional Pfizer and Moderna COVID boosters for adults 50 and older
By Lauran Neergaard, Matthew Perrone and The Associated PressMarch 29, 2022
Moderna vaccine full FDA approval
HealthModerna COVID-19 vaccine gets full approval from the FDA
By Matthew Perrone and The Associated PressJanuary 31, 2022
Merck covid 19 pill
HealthFDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
HealthPfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
HealthFDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By Lauran Neergaard, Matthew Perrone and The Associated PressNovember 19, 2021
Pfizer CEO Albert Bourla
HealthPfizer seeks emergency FDA authorization for COVID-19 pill
By Matthew Perrone and The Associated PressNovember 16, 2021
FDA authorizes COVID vaccine for kids ages 5 to 11
HealthFDA authorizes COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 29, 2021
Vaccines for kids
HealthFDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 26, 2021
Moderna vaccine
HealthFDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 20, 2021
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
HealthFDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By Lauran Neergaard, Matthew Perrone and The Associated PressOctober 14, 2021
FDA will not make a decision on Merck’s COVID antiviral pill until December
HealthFDA will not make a decision on Merck’s COVID antiviral pill until December
By Matthew Perrone and The Associated PressOctober 14, 2021
FDA debates timeline for administering Johnson & Johnson booster shots
HealthFDA debates timeline for administering Johnson & Johnson booster shots
By Matthew Perrone, Lauran Neergaard and The Associated PressOctober 13, 2021
1...
  • 4
  • 5
  • 6
  • 7
  • 8
8
Most Popular
Asia
Pentagon accuses Alibaba, Baidu and BYD, three of China's biggest companies, of supporting the Chinese militaryplaceholder alt text
By Kate O'Keeffe and BloombergJune 8, 2026
Economy
'We are rapidly running out of time': Watchdog sounds Social Security alarm after 22% cut confirmed for 2032placeholder alt text
By Nick LichtenbergJune 9, 2026
Success
Costco CEO Ron Vachris rose from forklift driver to the C-suite without a college degree: ‘Don’t chase a title’ is the career advice that got him thereplaceholder alt text
By Preston ForeJune 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.